Literature DB >> 26418232

CHILDHOOD MALTREATMENT AND THE COURSE OF DEPRESSIVE AND ANXIETY DISORDERS: THE CONTRIBUTION OF PERSONALITY CHARACTERISTICS.

Jacqueline G F M Hovens1, Erik J Giltay1, Albert M van Hemert1, Brenda W J H Penninx1,2,3.   

Abstract

BACKGROUND: We investigated the effect of childhood maltreatment on predicting the 4-year course of depressive and anxiety disorders and the possible mediating role of personality characteristics in the association between childhood maltreatment and illness course.
METHODS: Longitudinal data in a large sample of participants with baseline depressive and/or anxiety disorders (n = 1,474, 18-65 years) were collected in the Netherlands Study of Depression and Anxiety. At baseline, childhood maltreatment was assessed with a semistructured interview. Personality trait questionnaires (Neuroticism-Extroversion-Openness Five Factor Inventory, Mastery scale, and Leiden Index of Depression Sensitivity), recent stressful life events (List of Threatening Experiences Questionnaire), and psychosocial variables were administered. The Life Chart Interview was used to determine the time to remission of depressive and/or anxiety disorders.
RESULTS: At baseline, 846 participants (57.4%) reported any childhood maltreatment. Childhood maltreatment had a negative impact on psychosocial functioning and was predictive of more unfavorable personality characteristics and cognitive reactivity styles (P < 0.001). Childhood maltreatment was a significant predictor of lower likelihood of remission of depressive and/or anxiety disorders (HR = 0.94, P < 0.001). High levels of neuroticism, hopelessness, external locus of control, and low levels of extraversion were mediating the relationship between childhood maltreatment and 4-year remission of depressive and anxiety disorders.
CONCLUSIONS: Certain personality characteristics are key players in the mechanism linking childhood maltreatment to an adverse illness course of depressive and anxiety disorders. Early interventions--reducing neuroticism and hopelessness, and enhancing extraversion and locus of control--might contribute to a better prognosis in a "high-risk" group of depressive and anxiety disorders.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  anxiety disorders; childhood maltreatment; depressive disorders

Mesh:

Year:  2015        PMID: 26418232     DOI: 10.1002/da.22429

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  13 in total

1.  Associations among prenatal stress, maternal antioxidant intakes in pregnancy, and child temperament at age 30 months.

Authors:  L R Lipton; K J Brunst; S Kannan; Y-M Ni; H B Ganguri; R J Wright; M Bosquet Enlow
Journal:  J Dev Orig Health Dis       Date:  2017-06-27       Impact factor: 2.401

2.  Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment.

Authors:  Martí Santacana; Bárbara Arias; Marina Mitjans; Albert Bonillo; María Montoro; Sílvia Rosado; Roser Guillamat; Vicenç Vallès; Víctor Pérez; Carlos G Forero; Miquel A Fullana
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

3.  Gene-environment interaction: New insights into perceived parenting and social anxiety among adolescents.

Authors:  Viktoria Chubar; Karla Van Leeuwen; Patricia Bijttebier; Evelien Van Assche; Guy Bosmans; Wim Van den Noortgate; Ruud van Winkel; Luc Goossens; Stephan Claes
Journal:  Eur Psychiatry       Date:  2020-06-08       Impact factor: 5.361

4.  Genome-wide interaction study of a proxy for stress-sensitivity and its prediction of major depressive disorder.

Authors:  Aleix Arnau-Soler; Mark J Adams; Caroline Hayward; Pippa A Thomson
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

5.  Associations Among Depressive Symptoms, Childhood Abuse, Neuroticism, Social Support, and Coping Style in the Population Covering General Adults, Depressed Patients, Bipolar Disorder Patients, and High Risk Population for Depression.

Authors:  Jia Zhou; Lei Feng; Changqing Hu; Christine Pao; Le Xiao; Gang Wang
Journal:  Front Psychol       Date:  2019-06-05

6.  Childhood maltreatment experiences are associated with altered diffusion in occipito-temporal white matter pathways.

Authors:  Elizabeth A Olson; Tate A Overbey; Caroline G Ostrand; Diego A Pizzagalli; Scott L Rauch; Isabelle M Rosso
Journal:  Brain Behav       Date:  2019-11-26       Impact factor: 2.708

7.  Childhood trauma and cognitive biases associated with psychosis: A systematic review and meta-analysis.

Authors:  Jazz Croft; David Martin; Paul Madley-Dowd; Daniela Strelchuk; Jonathan Davies; Jon Heron; Christoph Teufel; Stanley Zammit
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

8.  Association Between Childhood Maltreatment, FKBP5 Gene Methylation, and Anxiety Symptoms Among Chinese Adolescents: A Nested Case-Control Study.

Authors:  Wenjian Lai; Wenyan Li; Xueying Du; Yangfeng Guo; Wanxin Wang; Lan Guo; Ciyong Lu
Journal:  Front Psychiatry       Date:  2022-02-03       Impact factor: 4.157

9.  The Association between Adverse Childhood Experiences and Personality, Emotions and Affect: Does Number and Type of Experiences Matter?

Authors:  Jessica M Grusnick; Emma Garacci; Christian Eiler; Joni S Williams; Leonard E Egede
Journal:  J Res Pers       Date:  2019-12-10

10.  Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression.

Authors:  R C Culverhouse; N L Saccone; A C Horton; Y Ma; K J Anstey; T Banaschewski; M Burmeister; S Cohen-Woods; B Etain; H L Fisher; N Goldman; S Guillaume; J Horwood; G Juhasz; K J Lester; L Mandelli; C M Middeldorp; E Olié; S Villafuerte; T M Air; R Araya; L Bowes; R Burns; E M Byrne; C Coffey; W L Coventry; K A B Gawronski; D Glei; A Hatzimanolis; J-J Hottenga; I Jaussent; C Jawahar; C Jennen-Steinmetz; J R Kramer; M Lajnef; K Little; H M Zu Schwabedissen; M Nauck; E Nederhof; P Petschner; W J Peyrot; C Schwahn; G Sinnamon; D Stacey; Y Tian; C Toben; S Van der Auwera; N Wainwright; J-C Wang; G Willemsen; I M Anderson; V Arolt; C Åslund; G Bagdy; B T Baune; F Bellivier; D I Boomsma; P Courtet; U Dannlowski; E J C de Geus; J F W Deakin; S Easteal; T Eley; D M Fergusson; A M Goate; X Gonda; H J Grabe; C Holzman; E O Johnson; M Kennedy; M Laucht; N G Martin; M R Munafò; K W Nilsson; A J Oldehinkel; C A Olsson; J Ormel; C Otte; G C Patton; B W J H Penninx; K Ritchie; M Sarchiapone; J M Scheid; A Serretti; J H Smit; N C Stefanis; P G Surtees; H Völzke; M Weinstein; M Whooley; J I Nurnberger; N Breslau; L J Bierut
Journal:  Mol Psychiatry       Date:  2017-04-04       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.